Abstract
Objectives: Corticosteroids represent one of the mainstays of medical management of chronic rhinosinusitis (CRS) in both locally acting topical and systemic derivations. The application of topical corticosteroids is limited by a variety of factors including patient compliance, positioning, and nasal anatomy. Systemic corticosteroids confer a risk of medical complication that restricts their ability to be used repeatedly. The objective of this publication is to review the evolution of the in-office intranasal placement of corticosteroids in the management of CRS. The efficacy, outcomes, and safety of a variety of corticosteroid-containing devices meant to be placed in an office setting are reviewed. Methods: Pertinent literature was reviewed and summarized beginning with the earliest reports of direct intralesional injection of corticosteroids up through manufactured modern-day bioresorbable implants that contain corticosteroids. Results: The utilization of in-office placement of corticosteroid-containing material and implants has rapidly evolved since the concept was introduced, particularly in the last decade. Modern-day corticosteroid-eluting implants are reliably placed in the office, yield results across a range of objective and subjective outcomes, may decrease the need for revision endoscopic sinus surgery, and have a favorable safety profile. Conclusions: In-office placement of corticosteroid-containing stents are a viable treatment option for select patients, particularly those wishing to avoid revision surgery, and should be considered an important adjunct for treatment of refractory CRS in an otolaryngologist’s armamentarium.
Original language | English (US) |
---|---|
Pages (from-to) | 314-319 |
Number of pages | 6 |
Journal | Ear, Nose and Throat Journal |
Volume | 100 |
Issue number | 5 |
DOIs | |
State | Published - Jun 2021 |
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article OptiNose sponsored the publishing costs for this publication.
Keywords
- chronic rhinosinusitis
- corticosteroids
- implants
- nasal polyps
ASJC Scopus subject areas
- Otorhinolaryngology